Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials

Background:. We introduce an innovative and novel technology that achieves scarless skin removal without the use of thermal energy. Microcoring technology (MCT) uses a modified, hollow hypodermic needle to remove skin safely and without a scar. This method is advantageous compared to other fractiona...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jason N. Pozner, MD, Suzanne L. Kilmer, MD, Roy G. Geronemus, MD, Megan Jack, MD, Jay A. Burns, MD, Michael S. Kaminer, MD
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/a95adf515d4541e4b75c4751b8722fca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a95adf515d4541e4b75c4751b8722fca
record_format dspace
spelling oai:doaj.org-article:a95adf515d4541e4b75c4751b8722fca2021-11-25T07:57:34ZCytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials2169-757410.1097/GOX.0000000000003905https://doaj.org/article/a95adf515d4541e4b75c4751b8722fca2021-10-01T00:00:00Zhttp://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003905https://doaj.org/toc/2169-7574Background:. We introduce an innovative and novel technology that achieves scarless skin removal without the use of thermal energy. Microcoring technology (MCT) uses a modified, hollow hypodermic needle to remove skin safely and without a scar. This method is advantageous compared to other fractional devices, given that it has the same benefits as energy-based devices (removal of skin cores without a scar), with the added value of immediate closure along the relaxed skin tension lines, with significantly less thermal energy. Methods:. Three prospective clinical safety trials analyzing MCT treatment on abdominal and facial skin (short- and long-term) are described. Results:. MCT treatment of human skin resulted in scarless skin removal that was well tolerated by patients. Healing occurred rapidly, with limited side effects. Skin area reduction (skin tightening) and increase in skin thickness were observed long term. Conclusions:. MCT treatment of human skin is safe and well tolerated. Although further studies on efficacy are required to evaluate the full potential of MCT in skin rejuvenation, early findings such as skin tightening and increase in skin thickness are encouraging.Jason N. Pozner, MDSuzanne L. Kilmer, MDRoy G. Geronemus, MDMegan Jack, MDJay A. Burns, MDMichael S. Kaminer, MDWolters KluwerarticleSurgeryRD1-811ENPlastic and Reconstructive Surgery, Global Open, Vol 9, Iss 10, p e3905 (2021)
institution DOAJ
collection DOAJ
language EN
topic Surgery
RD1-811
spellingShingle Surgery
RD1-811
Jason N. Pozner, MD
Suzanne L. Kilmer, MD
Roy G. Geronemus, MD
Megan Jack, MD
Jay A. Burns, MD
Michael S. Kaminer, MD
Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials
description Background:. We introduce an innovative and novel technology that achieves scarless skin removal without the use of thermal energy. Microcoring technology (MCT) uses a modified, hollow hypodermic needle to remove skin safely and without a scar. This method is advantageous compared to other fractional devices, given that it has the same benefits as energy-based devices (removal of skin cores without a scar), with the added value of immediate closure along the relaxed skin tension lines, with significantly less thermal energy. Methods:. Three prospective clinical safety trials analyzing MCT treatment on abdominal and facial skin (short- and long-term) are described. Results:. MCT treatment of human skin resulted in scarless skin removal that was well tolerated by patients. Healing occurred rapidly, with limited side effects. Skin area reduction (skin tightening) and increase in skin thickness were observed long term. Conclusions:. MCT treatment of human skin is safe and well tolerated. Although further studies on efficacy are required to evaluate the full potential of MCT in skin rejuvenation, early findings such as skin tightening and increase in skin thickness are encouraging.
format article
author Jason N. Pozner, MD
Suzanne L. Kilmer, MD
Roy G. Geronemus, MD
Megan Jack, MD
Jay A. Burns, MD
Michael S. Kaminer, MD
author_facet Jason N. Pozner, MD
Suzanne L. Kilmer, MD
Roy G. Geronemus, MD
Megan Jack, MD
Jay A. Burns, MD
Michael S. Kaminer, MD
author_sort Jason N. Pozner, MD
title Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials
title_short Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials
title_full Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials
title_fullStr Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials
title_full_unstemmed Cytrellis: A Novel Microcoring Technology for Scarless Skin Removal: Summary of Three Prospective Clinical Trials
title_sort cytrellis: a novel microcoring technology for scarless skin removal: summary of three prospective clinical trials
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/a95adf515d4541e4b75c4751b8722fca
work_keys_str_mv AT jasonnpoznermd cytrellisanovelmicrocoringtechnologyforscarlessskinremovalsummaryofthreeprospectiveclinicaltrials
AT suzannelkilmermd cytrellisanovelmicrocoringtechnologyforscarlessskinremovalsummaryofthreeprospectiveclinicaltrials
AT royggeronemusmd cytrellisanovelmicrocoringtechnologyforscarlessskinremovalsummaryofthreeprospectiveclinicaltrials
AT meganjackmd cytrellisanovelmicrocoringtechnologyforscarlessskinremovalsummaryofthreeprospectiveclinicaltrials
AT jayaburnsmd cytrellisanovelmicrocoringtechnologyforscarlessskinremovalsummaryofthreeprospectiveclinicaltrials
AT michaelskaminermd cytrellisanovelmicrocoringtechnologyforscarlessskinremovalsummaryofthreeprospectiveclinicaltrials
_version_ 1718413639461896192